A novel large regulator RNA, B2, partially overlaps the HEF1/NEDD9/Cas-L gene

International Journal of Molecular Medicine

Volumn 25, Issue 6, 2010, Pages 897-903

  Malleter, Marine ^a   Jacquot, Catherine ^a   Moreau, Dimitri ^a   Tomasoni, Christophe ^a   Tsvetanova, Marianna ^a   Chinou, Ioanna ^b   Juge, Marcel ^a   Pineau, Alain ^a   Le Pape, Patrice ^a   Roussakis, Christos ^a  

^a UNIVERSITÉ DE NANTES   (France)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

A190; B2; Cytostatic molecules; HEF1; Large non coding RNA; miRNA; Regulator RNA

Indexed keywords

GENOMIC DNA; HEF 1 PROTEIN; NUCLEAR RNA; PROTEIN; REGULATORY RNA SEQUENCE B2; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CARCINOMA CELL; CELL PROLIFERATION; CONTROLLED STUDY; CYTOSTASIS; EXON; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; INTRACELLULAR SPACE; LIVER; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; REGULATORY RNA SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN; THYMUS; UTERINE CERVIX; WILD TYPE;

EID: 77952748405     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm_00000420     Document Type: Article

References (20)

1. Lilenbaum RC, Herndon JE 2nd, List MA, Desch C, Watson DM, Miller AA, Graziano SL, Perry MC, Saville W, Chahinian P, Weeks JC, Holland JC, et al: Single-agent versus combination chemotherapy in advanced non-small-cell lung cancer: the cancer and leukemia group B (study 9730). J Clin Oncol 23:190-196, 2005. (Pubitemid 41702638)
2. Ettinger DS: Overview and state of the art in the management of lung cancer. Oncology 18: 3-9, 2004.
3. Carbonnelle D, Jacquot C, Lanco X, Le Dez G, Tomasoni C, Briand G, Tsotinis A, Calogeropoulou T and Roussakis C: Up-regulation of a novel mRNA (NY-CO-1) involved in the methyl 4-methoxy-3-(3-methyl-2-butenoyl) benzoate (VT1)-induced proliferation arrest of a non-small-cell lung carcinoma cell line (NSCLC-N6). Int J Cancer 92: 388-397, 2001. (Pubitemid 32249716)
4. Jacquot C, Carbonnelle D, Tomasoni C, Papaconstadinou A, Roussis V and Roussakis C: Identification of a novel putative non-coding RNA involved in proliferation arrest of a non-small cell lung carcinoma cell line treated with an original chemical substance, methyl-4-methoxy-3-(3-methyl-2-butanoyl) benzoate. Int J Oncol 25: 519-527, 2004.
5. Law SF, Estojak J, Wang B, Mysliwiec T, Kruh G and Golemis EA: Human enhancer of filamentation 1, a novel p130cas-like docking protein, associates with focal adhesion kinase and induces pseudohyphal growth in Saccharomyces cerevisiae. Mol Cell Biol 16: 3327-3337, 1996. (Pubitemid 26199852)
6. Law SF, Zhang YZ, Klein-Szanto AJ and Golemis EA: Cell cycle-regulated processing of HEF1 to multiple protein forms differentially targeted to multiple subcellular compartments. Mol Cell Biol 18: 3540-3551, 1998.
7. Law SF, O'Neill GM, Fashena SJ, Einarson MB and Golemis EA: The docking protein HEF1 is an apoptotic mediator at focal adhesion sites. Mol Cell Biol 20: 5184-5195, 2000.
8. O'Neill GM, Seo S, Serebriiskii IG, Lessin SR and Golemis EA: A new central scaffold for metastasis: parsing HEF1/Cas-L/NEDD9. Cancer Res 67: 8975-8979, 2007. (Pubitemid 47535876)
9. Singh MK, Dadke D, Nicolas E, Serebriiskii IG, Apostolou S, Canutescu A, Egleston BL and Golemis EA: A novel cas family member, HEPL, regulates FAK and cell spreading. Mol Biol Cell 19: 1627-1636, 2008. (Pubitemid 351805115)
10. Pugacheva EN and Golemis EA: HEF1-aurora A interactions: points of dialog between the cell cycle and cell attachment signaling networks. Cell Cycle 5: 384-391, 2006.
11. O'Neill GM and Golemis EA: Proteolysis of the docking protein HEF1 and implications for focal adhesion dynamics. Mol Cell Biol 21: 5094-5108, 2001.
12. Roussakis C, Gratas C, Audouin AF, Le Boterff J, Dabouis C, Andre MJ, Moyon E, Vo NH, Pradal G and Verbist JF: Study of in vitro drug sensitivity on a newly established cell line from a primary bronchial epidermoid carcinoma of human origin (NSCLCN6). Anticancer Res 11: 2239-2244, 1991.
13. Giard DJ, Aaronson SA, Todaro GJ, Arnstein P, Kersey JH, Dosik H and Parks WP: In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J Natl Cancer Inst 51: 1417-1423, 1973.
14. Liang P and Pardee AB: Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 257: 967-971, 1992.
15. Seidl CI, Stricker SH and Barlow DP: The imprinted Air ncRNA is an atypical RNAPII transcript that evades splicing and escapes nuclear export. EMBO J 25: 3565-3575, 2006.
16. Clerc P and Avner P: Role of the region 3' to Xist exon 6 in the counting process of X-chromosome inactivation. Nat Genet 19: 249-253, 1998. (Pubitemid 28309335)
17. Pauler FM, Koerner MV and Barlow DP: Silencing by imprinted noncoding RNAs: is transcription the answer? Trends Genet 23: 284-292, 2007.
18. Cai X and Cullen BR: The imprinted H19 noncoding RNA is a primary microRNA precursor. RNA 13: 313-316, 2007. (Pubitemid 46327534)
19. Dadke D, Jarnik M, Pugacheva EN, Singh MK and Golemis EA: Deregulation of HEF1 impairs M-phase progression by disrupting the RhoA activation cycle. Mol Biol Cell 17: 1204-1217, 2006. (Pubitemid 43376542)
20. Moreau D, Jacquot C, Tsita P, Chinou I, Tomasoni C, Juge M, Antoniadou-Vyza E, Martignat L, Pineau A and Roussakis C: Original triazine inductor of new specific molecular targets, with antitumor activity against non-small cell lung cancer. Int J Cancer 123: 2676-2683, 2008.